Get started
Zomedica Corp.Zomedica Corp.Zomedica Corp.

Zomedica Corp.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

ZOM trade ideas

$ZOM Potent investment opportunityObserving the trading chart for this particular equity, it's evident that the security has been encapsulated in a range-bound, or "rectangular," pattern since 2018, with the central pivot point firmly established in the $0.20 vicinity. This technical analysis, combined with strategic stock purchases by the CEO and other insiders, signals a strong vote of confidence in the company's prospects. When we scrutinize the fundamentals, the recent earnings report paints an encouraging picture: a robust 43% surge in revenue, bringing it to $6.0 million, bolstered by an impressive gross margin of 67%. Additionally, the company's liquidity position remains strong, with $142.4 million on hand, providing ample financial flexibility. Given this confluence of positive signals, both from a technical and fundamental perspective, there's a compelling case to be made for this stock as a potent investment opportunity at this junction.
AMEX:ZOMLong
by AllHart
ZOM LongPrice has been consolidating in the .24-.25 range since May which is also in very close proximity to the POC (12 Month) suggesting this could be a low risk entry point as the most shares traded in 12 months has been at .2424 cents. The Force Index is curling up, the D+ crossed the D- on the ADX and the MACD just crossed. These indicators in addition to the most recent candle taking out the 1 Fibonacci level give a very bullish forecast. targeting: .3036, .3655
AMEX:ZOMLong
by Master_of_Fine_Charts
3
Zom slowly waking upNot a Financial advisor. Zom appears to have found a potential bottom - awaiting this week to close (market rebounding - should look to be green) This is a satisfying entry level for me personally to go long. Lower time frames a bit more bullish than the weekly. Should translate to the higher times. Looking for this to regain control to the .50s in Feb - dependent on the market. But we should definitely see a bit of relief here, still early - which is the risk I'm willing to take. Won't be paying much attention here yet - needs more time.
AMEX:ZOM
by StofAxeCapital